Literature DB >> 12909650

Detection of Clostridium difficile cytotoxin and Clostridium perfringens enterotoxin in cases of diarrhoea in the community.

L J Forward1, D S Tompkins1, M M Brett1.   

Abstract

Faecal specimens from 843 cases of diarrhoea in the community were tested for the presence of Clostridium difficile cytotoxin and Clostridium perfringens enterotoxin. C. difficile cytotoxin was detected in faecal specimens from 0.6 % of cases aged at least 2 years by using a Vero cell assay. Factors associated with detection of C. difficile cytotoxin were antibiotic therapy, age over 60 years and living in a home with other elderly people. Three methods were used for the detection of C. perfringens enterotoxin: a Vero cell assay, a commercial (TechLab) enzyme immunoassay (EIA) and an in-house EIA. The lower level of detection of pure C. perfringens enterotoxin in buffer was 0.01 micro g ml(-1) by the TechLab EIA and 1.0 micro g ml(-1) by the Vero cell assay. C. perfringens enterotoxin was detected by using the TechLab EIA in faecal specimens from 2.5 % of cases. This commercial EIA was less sensitive than the in-house EIA, detecting only 31 % of positive cases, but was specific and could be used for outbreak investigation by routine diagnostic laboratories. Age over 60 years was a factor associated with C. perfringens enterotoxin detection; this age group may be targeted for testing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909650     DOI: 10.1099/jmm.0.05119-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  8 in total

1.  Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.

Authors:  N J Asha; D Tompkins; M H Wilcox
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Bacteriological evaluation of commercial canine and feline raw diets.

Authors:  J Scott Weese; Joyce Rousseau; L Arroyo
Journal:  Can Vet J       Date:  2005-06       Impact factor: 1.008

3.  Multiplex PCR genotyping assay that distinguishes between isolates of Clostridium perfringens type A carrying a chromosomal enterotoxin gene (cpe) locus, a plasmid cpe locus with an IS1470-like sequence, or a plasmid cpe locus with an IS1151 sequence.

Authors:  Kazuaki Miyamoto; Qiyi Wen; Bruce A McClane
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  High Incidence of Staphylococcus aureus and Norovirus Gastroenteritis in Infancy: A Single-Center, 1-Year Experience.

Authors:  Kyoung Sung; Ji Yong Kim; Yeoun Joo Lee; Eun Ha Hwang; Jae Hong Park
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-09-30

5.  Sensitive quantification of Clostridium perfringens in human feces by quantitative real-time PCR targeting alpha-toxin and enterotoxin genes.

Authors:  Ravinder Nagpal; Kiyohito Ogata; Hirokazu Tsuji; Kazunori Matsuda; Takuya Takahashi; Koji Nomoto; Yoshio Suzuki; Kazunari Kawashima; Satoru Nagata; Yuichiro Yamashiro
Journal:  BMC Microbiol       Date:  2015-10-19       Impact factor: 3.605

6.  Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran.

Authors:  Masoumeh Azimirad; Fatemeh Gholami; Abbas Yadegar; Daniel R Knight; Sharareh Shamloei; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Sci Rep       Date:  2019-05-24       Impact factor: 4.379

7.  Prevalence and Genetic Diversity of Toxin Genes in Clinical Isolates of Clostridium perfringens: Coexistence of Alpha-Toxin Variant and Binary Enterotoxin Genes (bec/cpile).

Authors:  Asami Matsuda; Meiji Soe Aung; Noriko Urushibara; Mitsuyo Kawaguchiya; Ayako Sumi; Mayumi Nakamura; Yuka Horino; Masahiko Ito; Satoshi Habadera; Nobumichi Kobayashi
Journal:  Toxins (Basel)       Date:  2019-06-06       Impact factor: 4.546

8.  Prevalence and Genetic Diversity of Clostridium perfringens Isolates in Hospitalized Diarrheal Patients from Central China.

Authors:  Baoya Wang; Wenjuan Dong; Liyan Ma; Yonghui Dong; Shanmei Wang; Youhua Yuan; Qiong Ma; Junhong Xu; Wenjuan Yan; Jing Nan; Qi Zhang; Wenbo Xu; Bing Ma; Yafei Chu; Jiangfeng Zhang; Li Li; Yi Li
Journal:  Infect Drug Resist       Date:  2021-11-15       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.